CD19 and B-cell neoplasm: We isolated primary tumors and peripheral blood mononuclear cells (PBMCs) from three patients with B cell neoplasms expressing heterogeneous levels of CD19 (patient 1 diagnosed with marginal zone lymphoma [MZL] and patients 2 and 3 with CLL), (Figure 4A).